Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 366

1.

Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?

Keating NL, Landrum MB, Klabunde CN, Fletcher RH, Rogers SO, Doucette WR, Tisnado D, Clauser S, Kahn KL.

J Clin Oncol. 2008 May 20;26(15):2532-7. doi: 10.1200/JCO.2007.15.9434.

2.

Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.

Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC.

J Am Coll Surg. 2009 Feb;208(2):202-9. doi: 10.1016/j.jamcollsurg.2008.10.016. Epub 2008 Dec 18.

PMID:
19228531
3.

Patient age and cancer treatment decisions. Patient and physician views.

Kutner JS, Vu KO, Prindiville SA, Byers TE.

Cancer Pract. 2000 May-Jun;8(3):114-9.

PMID:
11898135
4.

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.

Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, O'Connor LC, West DW, Allen ME, Wolf RE, Wright WE.

J Clin Oncol. 2003 Apr 1;21(7):1293-300.

PMID:
12663717
5.

Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.

Ananda S, Field KM, Kosmider S, Compston D, Desai J, Lim LC, Barnett FS, Jones IT, Skinner I, Gibbs P.

J Clin Oncol. 2008 Sep 20;26(27):4516-7; author reply 4517-8. doi: 10.1200/JCO.2008.18.7443. No abstract available.

7.

The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.

Gross CP, McAvay GJ, Guo Z, Tinetti ME.

Cancer. 2007 Jun 15;109(12):2410-9.

8.

Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Schrag D, Cramer LD, Bach PB, Begg CB.

J Natl Cancer Inst. 2001 Jun 6;93(11):850-7.

9.

Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands.

van Steenbergen LN, Rutten HJ, Creemers GJ, Pruijt JF, Coebergh JW, Lemmens VE.

Ann Oncol. 2010 Jun;21(6):1273-8. doi: 10.1093/annonc/mdp482. Epub 2009 Oct 30.

10.

Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients.

Mahoney T, Kuo YH, Topilow A, Davis JM.

Arch Surg. 2000 Feb;135(2):182-5.

PMID:
10668878
11.

Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity.

Rogers SO Jr, Gray SW, Landrum MB, Klabunde CN, Kahn KL, Fletcher RH, Clauser S, Tisnado D, Doucette W, Keating NL.

Ann Surg Oncol. 2010 Jun;17(6):1581-8. doi: 10.1245/s10434-010-0946-y. Epub 2010 Feb 17.

12.

Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factors.

Lee IH, Hayman JA, Landrum MB, Tepper J, Tao ML, Goodman KA, Keating NL.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1376-84. doi: 10.1016/j.ijrobp.2008.10.066. Epub 2009 May 4.

13.

Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces.

Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG.

Can J Surg. 2009 Apr;52(2):92-7.

14.

Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.

Alter E, Phelip JM, Guilhot JN, Matysiak M, Vermorel M, Roblin X.

Eur J Gastroenterol Hepatol. 2007 Nov;19(11):995-1001.

PMID:
18049170
15.

Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.

Neugut AI, Matasar M, Wang X, McBride R, Jacobson JS, Tsai WY, Grann VR, Hershman DL.

J Clin Oncol. 2006 May 20;24(15):2368-75. Epub 2006 Apr 17.

16.

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG.

J Clin Oncol. 2004 Aug 15;22(16):3408-19. Epub 2004 Jun 15. Review.

PMID:
15199089
17.

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB.

J Clin Oncol. 2002 Oct 1;20(19):3999-4005.

PMID:
12351597
18.

Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review.

Etzioni DA, El-Khoueiry AB, Beart RW Jr.

Cancer. 2008 Dec 15;113(12):3279-89. doi: 10.1002/cncr.23958. Review.

19.

Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.

Hurria A, Naeim A, Elkin E, Limaye S, Grover A, Hudis C, Pearce C, Robson M.

Crit Rev Oncol Hematol. 2007 Mar;61(3):255-60. Epub 2006 Nov 13.

PMID:
17098441
20.

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.

Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM; Norwegian Gastrointestinal Cancer Group.

Acta Oncol. 2009;48(3):368-76. doi: 10.1080/02841860902755244.

PMID:
19242829
Items per page

Supplemental Content

Write to the Help Desk